Skip to main content

Table 2 Number of samples and frequency for KCNH2, SCN5A, ITGB1 and SLC9A1 subgroups of expression

From: Clinical relevance of macromolecular complexes involving integrins, potassium and sodium ion channels and the sodium/proton antiporter in human breast cancer

 

N

Frequency

KCNH2

(N = 1203)

Low expression

400

33.25%

Middle expression

402

33.42%

High expression

401

33.33%

SCN5A

(N = 1203)

Low expression

397

33.00%

Middle expression

403

33.50%

High expression

403

33.50%

ITGB1

(N = 1203)

Low expression

399

33.17%

Middle expression

402

33.42%

High expression

402

33.42%

SLC9A1

(N = 1203)

Low expression

402

33.42%

Middle expression

404

33.58%

High expression

397

33.00%